Larvol Delta - Viracta-Therapeutics-Pivotal-NAVAL1-Trial-Achieves-Efcacy-Threshold-for-Expansion-in-Relapsed-or-Refractory-EBVpositive-Peripheral-TCell-Lymphoma-RR-EBV-PTCL

Valcyte (valganciclovir) - Roche, Mitsubishi Tanabe

nanatinostat (VRx-3996) - Viracta Therap

https://www.globenewswire.com/news-release/2023/06/28/2696137/0/en/Viracta-Therapeutics-Pivotal-NAVAL-1-Trial-Achieves-Efficacy-Threshold-for-Expansion-in-Relapsed-or-Refractory-EBV-positive-Peripheral-T-Cell-Lymphoma-R-R-EBV-PTCL.html

Jun 28, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next